Study discovers method to classify febrile illness with a single blood sample

FHS
August 28, 2023
10:33 am

Researchers trained machine learning (ML) models to analyze RNA molecular signatures in patients’ blood.

Lyndra appoints Adam Sayer as new CEO and president

The company’s upcoming pivotal safety trial for LYN-005 is scheduled to begin in the first half of 2025. Credit: PeopleImages.com – Yuri A/Shutterstock. Lyndra Therapeutics

January 29, 2025

Report shows U.S. biotechs are wary of Chinese partnerships due to looming BIOSECURE Act

A looming anti-China biotechnology bill has spooked U.S. life sciences companies, according to a new report. The report by the China-based L.E.K. Consulting quantifies what

July 2, 2024

Your doctor or your insurer? Little-known rules may ease the choice in Medicare Advantage

Bart Klion, 95, and his wife, Barbara, faced a tough choice in January: The upstate New York couple learned that this year they could keep

March 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.